Psychedelics: Stepping Into the Unknown on SBS –Anxiety is the most common group of mental disorders experienced by Australians aged 16 to 85, according to the latest ABS figures i. Could psychedelic assisted therapy hold the answer to our mental illness epidemic?
This is the question explored in Psychedelics: Stepping into the Unknown – the thrilling final instalment in the third season of Australia Uncovered.
As the head of Australia’s first clinical psychedelic laboratory, Dr Paul Liknaitzky is fast emerging as a leader in this ground-breaking area of research. In a world first, Dr Liknaitzky and his team at Monash University trial the use of psilocybin (the active ingredient found in ‘magic mushrooms’) in psychedelic assisted therapy to treat Generalised Anxiety Disorder (GAD). For two years, Psychedelics: Stepping into the Unknown is granted exclusive access to what unfolds.
We meet the participants before their treatment begins and witness their daily struggles living with anxiety. We follow them through treatment, including extraordinary psychedelic dosing sessions, and intense and intimate therapy. Their experiences are raw, courageous, and life changing.
Psychedelics: Stepping Into the Unknown on SBS and SBS on Demand – Premiere / Thursday 29 February at 8.40pm
TV Central SBS content HERE
